Haemonetics Gross Margin 2012-2026 | HAE
Current and historical gross margin for Haemonetics (HAE) over the last 10 years. The current gross profit margin for Haemonetics as of June 30, 2026 is %.
| Haemonetics Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2026-06-30 | $1.35B | $0.80B | 59.07% |
| 2026-03-31 | $1.33B | $0.79B | 59.04% |
| 2025-12-31 | $1.32B | $0.78B | 59.33% |
| 2025-09-30 | $1.33B | $0.77B | 58.28% |
| 2025-06-30 | $1.35B | $0.77B | 56.87% |
| 2025-03-31 | $1.36B | $0.75B | 54.99% |
| 2024-12-31 | $1.37B | $0.73B | 53.28% |
| 2024-09-30 | $1.36B | $0.72B | 52.61% |
| 2024-06-30 | $1.33B | $0.70B | 52.51% |
| 2024-03-31 | $1.31B | $0.69B | 52.91% |
| 2023-12-31 | $1.27B | $0.67B | 52.96% |
| 2023-09-30 | $1.24B | $0.65B | 52.75% |
| 2023-06-30 | $1.22B | $0.64B | 52.59% |
| 2023-03-31 | $1.17B | $0.62B | 52.70% |
| 2022-12-31 | $1.13B | $0.60B | 52.75% |
| 2022-09-30 | $1.08B | $0.58B | 53.09% |
| 2022-06-30 | $1.03B | $0.54B | 52.63% |
| 2022-03-31 | $0.99B | $0.51B | 50.91% |
| 2021-12-31 | $0.95B | $0.45B | 47.38% |
| 2021-09-30 | $0.93B | $0.43B | 46.36% |
| 2021-06-30 | $0.90B | $0.42B | 46.07% |
| 2021-03-31 | $0.87B | $0.40B | 45.75% |
| 2020-12-31 | $0.88B | $0.43B | 48.70% |
| 2020-09-30 | $0.90B | $0.44B | 48.56% |
| 2020-06-30 | $0.95B | $0.46B | 48.52% |
| 2020-03-31 | $0.99B | $0.49B | 49.09% |
| 2019-12-31 | $1.00B | $0.48B | 48.25% |
| 2019-09-30 | $0.99B | $0.47B | 47.11% |
| 2019-06-30 | $0.98B | $0.45B | 46.11% |
| 2019-03-31 | $0.97B | $0.42B | 43.12% |
| 2018-12-31 | $0.95B | $0.41B | 43.07% |
| 2018-09-30 | $0.94B | $0.41B | 43.66% |
| 2018-06-30 | $0.92B | $0.40B | 43.71% |
| 2018-03-31 | $0.90B | $0.41B | 45.58% |
| 2017-12-31 | $0.90B | $0.39B | 43.43% |
| 2017-09-30 | $0.89B | $0.38B | 42.60% |
| 2017-06-30 | $0.89B | $0.38B | 42.73% |
| 2017-03-31 | $0.89B | $0.38B | 42.66% |
| 2016-12-31 | $0.90B | $0.39B | 42.78% |
| 2016-09-30 | $0.91B | $0.39B | 43.43% |
| 2016-06-30 | $0.91B | $0.39B | 43.54% |
| 2016-03-31 | $0.91B | $0.41B | 44.71% |
| 2015-12-31 | $0.89B | $0.43B | 47.65% |
| 2015-09-30 | $0.89B | $0.43B | 48.04% |
| 2015-06-30 | $0.90B | $0.43B | 47.94% |
| 2015-03-31 | $0.91B | $0.43B | 47.69% |
| 2014-12-31 | $0.93B | $0.44B | 47.68% |
| 2014-09-30 | $0.94B | $0.45B | 48.24% |
| 2014-06-30 | $0.94B | $0.46B | 49.10% |
| 2014-03-31 | $0.94B | $0.47B | 49.84% |
| 2013-12-31 | $0.95B | $0.48B | 50.21% |
| 2013-09-30 | $0.95B | $0.47B | 49.00% |
| 2013-06-30 | $0.94B | $0.45B | 48.02% |
| 2013-03-31 | $0.89B | $0.43B | 48.04% |
| 2012-12-31 | $0.83B | $0.40B | 48.31% |
| 2012-09-30 | $0.77B | $0.38B | 49.61% |
| 2012-06-30 | $0.73B | $0.37B | 50.61% |
| 2012-03-31 | $0.73B | $0.37B | 50.82% |
| 2011-12-31 | $0.71B | $0.36B | 51.05% |
| 2011-09-30 | $0.70B | $0.36B | 51.65% |
| 2011-06-30 | $0.69B | $0.36B | 52.26% |
| 2011-03-31 | $0.68B | $0.36B | 52.44% |
| 2010-12-31 | $0.68B | $0.36B | 52.51% |
| 2010-09-30 | $0.66B | $0.35B | 52.26% |
| 2010-06-30 | $0.65B | $0.34B | 51.99% |
| 2010-03-31 | $0.65B | $0.34B | 52.25% |
| 2009-12-31 | $0.63B | $0.33B | 52.71% |
| 2009-09-30 | $0.62B | $0.32B | 52.43% |
| 2009-06-30 | $0.61B | $0.32B | 52.39% |
| 2009-03-31 | $0.60B | $0.31B | 51.59% |
| 2008-12-31 | $0.58B | $0.30B | 50.68% |
| 2008-09-30 | $0.56B | $0.29B | 50.53% |
| 2008-06-30 | $0.54B | $0.27B | 50.09% |
| 2008-03-31 | $0.52B | $0.26B | 49.90% |
| 2007-12-31 | $0.50B | $0.25B | 49.70% |
| 2007-09-30 | $0.47B | $0.24B | 49.58% |
| 2007-06-30 | $0.46B | $0.23B | 49.89% |
| 2007-03-31 | $0.45B | $0.23B | 50.22% |
| 2006-12-31 | $0.44B | $0.23B | 51.24% |
| 2006-09-30 | $0.44B | $0.23B | 52.18% |
| 2006-06-30 | $0.43B | $0.22B | 52.46% |
| 2006-03-31 | $0.42B | $0.22B | 52.98% |
| 2005-12-31 | $0.41B | $0.22B | 52.81% |
| 2005-09-30 | $0.40B | $0.21B | 52.87% |
| 2005-06-30 | $0.39B | $0.21B | 52.55% |
| 2005-03-31 | $0.38B | $0.20B | 51.56% |
| 2004-12-31 | $0.38B | $0.19B | 50.79% |
| 2004-09-30 | $0.38B | $0.19B | 49.33% |
| 2004-06-30 | $0.37B | $0.18B | 48.79% |
| 2004-03-31 | $0.36B | $0.17B | 47.80% |
| 2003-12-31 | $0.35B | $0.16B | 46.40% |
| 2003-09-30 | $0.34B | $0.16B | 46.36% |
| 2003-06-30 | $0.34B | $0.16B | 45.48% |
| 2003-03-31 | $0.34B | $0.16B | 45.99% |
| 2002-12-31 | $0.34B | $0.16B | 46.57% |
| 2002-09-30 | $0.33B | $0.16B | 46.99% |
| 2002-06-30 | $0.33B | $0.16B | 48.16% |
| 2002-03-31 | $0.32B | $0.15B | 48.13% |
| 2001-12-31 | $0.32B | $0.15B | 47.95% |
| 2001-09-30 | $0.31B | $0.15B | 48.54% |
| 2001-06-30 | $0.30B | $0.14B | 47.83% |
| 2001-03-31 | $0.29B | $0.14B | 47.78% |
| 2000-12-31 | $0.29B | $0.14B | 48.43% |
| 2000-09-30 | $0.28B | $0.13B | 47.16% |
| 2000-06-30 | $0.28B | $0.13B | 47.31% |
| 2000-03-31 | $0.28B | $0.13B | 47.48% |
| 1999-12-31 | $0.28B | $0.13B | 47.16% |
| 1999-09-30 | $0.28B | $0.13B | 46.95% |
| 1999-06-30 | $0.28B | $0.13B | 46.95% |
| 1999-03-31 | $0.28B | $0.13B | 47.52% |
| 1998-12-31 | $0.27B | $0.14B | 51.66% |
| 1998-09-30 | $0.27B | $0.14B | 50.92% |
| 1998-06-30 | $0.28B | $0.14B | 49.28% |
| 1998-03-31 | $0.29B | $0.14B | 47.37% |
| 1997-12-31 | $0.30B | $0.13B | 43.23% |
| 1997-09-30 | $0.31B | $0.14B | 44.63% |
| 1997-06-30 | $0.31B | $0.15B | 47.56% |
| 1997-03-31 | $0.30B | $0.15B | 50.83% |
| 1996-12-31 | $0.29B | $0.16B | 53.77% |
| 1996-09-30 | $0.29B | $0.16B | 55.56% |
| 1996-06-30 | $0.28B | $0.16B | 56.34% |
| 1996-03-31 | $0.28B | $0.16B | 55.76% |
| 1995-12-31 | $0.28B | $0.15B | 54.71% |
| 1995-09-30 | $0.27B | $0.15B | 54.41% |
| 1995-06-30 | $0.27B | $0.15B | 54.48% |
| 1995-03-31 | $0.26B | $0.15B | 55.34% |
| 1994-12-31 | $0.26B | $0.15B | 56.59% |
| 1994-09-30 | $0.26B | $0.15B | 57.65% |
| 1994-06-30 | $0.25B | $0.15B | 58.10% |
| 1994-03-31 | $0.25B | $0.14B | 57.83% |
| 1993-12-31 | $0.24B | $0.14B | 57.44% |
| 1993-09-30 | $0.24B | $0.13B | 56.36% |
| 1993-06-30 | $0.23B | $0.13B | 55.31% |
| 1993-03-31 | $0.22B | $0.12B | 54.63% |
| 1992-12-31 | $0.21B | $0.11B | 54.11% |
| 1992-09-30 | $0.20B | $0.11B | 53.85% |
| 1992-06-30 | $0.19B | $0.10B | 52.97% |
| 1992-03-31 | $0.18B | $0.09B | 52.27% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $4.837B | $1.334B |
| Haemonetics Corp. provides blood management solutions to customers encompassing blood and plasma collectors, hospitals and health care providers globally. Its portfolio of integrated devices, information management, and consulting services offers blood management solutions for each facet of the blood supply chain, helping better clinical outcomes. It acquired Pall Corporation's blood collection, filtration and processing product lines. It entered into a long-term supply agreement with Pall. The company acquired Hemerus Medical. It operates under 3 segments: Plasma, Blood Center, and Hospital. Plasma includes plasma collection devices and disposables, plasma donor management software, anticoagulant and saline sold to plasma customers. Blood Center includes blood collection and processing devices and disposables for red cells, platelets and whole blood as well as related donor management software. Hospital includes three product lines, namely, Hemostasis Management, Cell Salvage and Transfusion Management. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $178.385B | 19.60 |
| Medtronic (MDT) | Ireland | $119.983B | 16.40 |
| Stryker (SYK) | United States | $108.118B | 20.21 |
| EssilorLuxottica (ESLOY) | France | $79.433B | 0.00 |
| Boston Scientific (BSX) | United States | $65.288B | 14.03 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.930B | 0.00 |
| Medline (MDLN) | United States | $42.846B | 0.00 |
| Agilent Technologies (A) | United States | $41.387B | 24.22 |
| ResMed (RMD) | United States | $32.167B | 19.96 |
| GE HealthCare Technologies (GEHC) | United States | $29.021B | 13.88 |
| Koninklijke Philips (PHG) | Netherlands | $24.651B | 13.13 |
| Terumo (TRUMY) | Japan | $21.625B | 20.65 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.414B | 11.38 |
| Baxter (BAX) | United States | $12.336B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.926B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.854B | 39.71 |
| Demant (WILYY) | Denmark | $9.592B | 0.00 |
| Insulet (PODD) | United States | $9.557B | 23.48 |
| Sunny Optical Technology (SNPTF) | China | $9.142B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.548B | 20.15 |
| Raia Drogasil SA - (RADLY) | $4.931B | 0.00 | |
| BillionToOne (BLLN) | United States | $4.757B | 144.03 |
| DiaSorin S.p.A (DSRLF) | Italy | $4.705B | 0.00 |
| Envista Holdings (NVST) | United States | $4.142B | 17.54 |
| ICU Medical (ICUI) | United States | $3.939B | 23.52 |
| AtriCure (ATRC) | United States | $2.838B | 242.57 |
| Neogen (NEOG) | United States | $2.606B | 45.96 |
| Curaleaf Holdings (CURLD) | Canada | $2.388B | 0.00 |
| Curaleaf Holdings (CURLF) | United States | $2.356B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.256B | 10.77 |
| Trulieve Cannabis (TRLV) | United States | $2.238B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.207B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.894B | 5.46 |
| LeMaitre Vascular (LMAT) | United States | $1.847B | 29.69 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $1.798B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.736B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.733B | 221.44 |
| Phibro Animal Health (PAHC) | United States | $1.459B | 11.20 |
| Green Thumb Industries (GTBIF) | United States | $1.428B | 15.23 |
| Kestra Medical Technologies (KMTS) | United States | $1.410B | 0.00 |
| Omeros (OMER) | United States | $1.264B | 6.40 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.094B | 0.00 |
| CeriBell (CBLL) | United States | $0.934B | 0.00 |
| InMode (INMD) | Israel | $0.856B | 11.91 |
| AdaptHealth (AHCO) | United States | $0.802B | 16.80 |
| VAREX IMAGING (VREX) | United States | $0.777B | 17.09 |
| QuidelOrtho (QDEL) | United States | $0.763B | 8.24 |
| Glass House Brands (GLAS) | United States | $0.760B | 0.00 |
| Valneva SE (VALN) | France | $0.633B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.582B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.564B | 0.00 |
| Brainsway (BWAY) | Israel | $0.548B | 30.98 |
| Evolus (EOLS) | United States | $0.524B | 0.00 |
| Cerus (CERS) | United States | $0.514B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.512B | 0.00 |
| Vireo Growth (VREOD) | United States | $0.451B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.438B | 0.00 |
| Verano Holdings (VRNOD) | United States | $0.425B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.422B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.395B | 8.28 |
| Cresco Labs (CRLBF) | United States | $0.373B | 0.00 |
| SNDL (SNDL) | Canada | $0.353B | 0.00 |
| Village Farms (VFF) | Canada | $0.347B | 15.78 |
| Viemed Healthcare (VMD) | United States | $0.337B | 24.56 |
| Sanara MedTech (SMTI) | United States | $0.321B | 159.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.294B | 0.00 |
| MacroGenics (MGNX) | United States | $0.268B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.247B | 13.14 |
| High Tide (HITI) | Canada | $0.234B | 52.60 |
| OraSure Technologies (OSUR) | United States | $0.232B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.225B | 21.55 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.194B | 0.00 |
| Exagen (XGN) | United States | $0.178B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Jin Medical (ZJYL) | China | $0.155B | 0.00 |
| Organigram Global (OGI) | Canada | $0.152B | 0.00 |
| Apyx Medical (APYX) | United States | $0.127B | 0.00 |
| Quanterix (QTRX) | United States | $0.118B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| ImmuCell (ICCC) | United States | $0.088B | 121.38 |
| Accendra Health (ACH) | United States | $0.086B | 4.87 |
| FitLife Brands (FTLF) | United States | $0.086B | 11.30 |
| Jushi Holdings (JUSHF) | United States | $0.083B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| InterCure (INCR) | Israel | $0.058B | 0.00 |
| Hongchang (HCIL) | China | $0.052B | 0.00 |
| Biote (BTMD) | United States | $0.050B | 4.12 |
| Nephros (NEPH) | United States | $0.048B | 40.27 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.037B | 17.71 |
| United-Guardian (UG) | United States | $0.033B | 13.26 |
| Rockwell Medical (RMTI) | United States | $0.031B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.022B | 0.00 |
| Modular Medical (MODD) | United States | $0.021B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.019B | 0.00 |
| Bonk (BNKK) | United States | $0.011B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Agape ATP (ATPC) | $0.002B | 0.00 | |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.000B | 0.00 |
| INLIF (INLF) | China | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |